Stage III B cervical poorly/moderately differentiated adenocarcinoma. PELVIS:UTERUS, ADNEXA: The uterus measures 5.1 x 2.9 cm in the sagittal plane, within normal limits for a postmenopausal patient.The endometrium measures 3 mm in thickness, within normal limits.The endometrium/inner myometrial junction is well-defined. The fundus there is a well-defined 1.1 cm T1 iso and T2 hypoechoic lesion compatible with a intramural/submucosal fibroid.The cervical stroma demonstrates normal intermediate T2-weighted signal intensity without a discrete lesion. Postcontrast and restricted diffusion images demonstrate no discrete measurable lesion. The parametrial soft tissues are unremarkable.The adnexa are unremarkable. BLADDER: No significant abnormality noted.LYMPH NODES: Interval decrease in size of pelvic lymph nodes. The left internal iliac lymph node measures 0.9 x 0.6 cm (series 601/46), compared to 1.3 x 0.8 cm previously (series 3/3).BOWEL, MESENTERY: No significant abnormality noted.BONES, SOFT TISSUES: No significant abnormality noted.OTHER: No significant abnormality noted.
Interval marked decrease in the cervical mass lesion seen on the prior outside MRI dated 10/8/2015 without a measurable residual lesion. The parametrial soft tissues are unremarkable. The pelvic lymph nodes, including a previously mildly enlarged FDG avid left internal iliac lymph node has decreased in size. 